News | Breast Imaging | August 02, 2019

Volpara will sell artificial intelligence-powered breast cancer detection solution in the U.S., Australia, New Zealand and parts of Asia

Volpara to Distribute Screenpoint Medical's Transpara AI Solution

August 2, 2019 — Volpara Solutions and ScreenPoint Medical BV signed an agreement under which Volpara will sell ScreenPoint's Transpara products to breast imaging clinics in the United States, Australia, New Zealand and parts of Asia. Transpara is designed to assist radiologists with the reading of mammograms and is one of the first next-generation artificial intelligence (AI) applications for detecting breast cancer in screening mammograms to gain 510(k) clearance from the U.S. Food & Drug Administration (FDA).

FDA clearance was supported by the results of a multi-reader, multi-case reader study published in February 2019 in Radiology, which demonstrated that radiologists using Transpara significantly improved detection accuracy without increasing reading times.1 Radiologists' performance consistently improved independent of their level of experience. In the JNCI publication that followed in March, it was reported that when compared to 101 radiologists, the stand-alone performance (sensitivity and specificity) of Transpara was as accurate.2 This suggests that the system gives an objective second opinion similar to that of a second radiologist. 

Transpara gained European regulatory approval (CE) for use with multi-vendor mammography (2018) and digital breast tomosynthesis (DBT) images (2019), and is already installed at breast imaging centers in Europe.

Both companies showcased their complete suite of breast imaging analytics tools at the Association for Medical Imaging Management (AHRA) 2019 Annual Meeting, July 21-24 in Denver.

For more information: www.volparasolutions.com, www.screenpoint-medical.com

Reference

1. Rodriguez-Ruiz A., Krupinski E., Mordang J., et al. Detection of Breast Cancer with Mammography: Effect of an Artificial Intelligence Support System. Radiology, published online Nov. 20, 2018. https://doi.org/10.1148/radiol.2018181371

2. Rodriguez-Ruiz A., Lang K., Gubern-Merida A., et al. Stand-Alone Artificial Intelligence for Breast Cancer Detection in Mammography: Comparison With 101 Radiologists. Journal of the National Cancer Institute, March 5, 2019. https://doi.org/10.1093/jnci/djy222


Related Content

News | Artificial Intelligence

November 28, 2023 — Combining Vista.ai's leading radiology AI-guided software that automates MRI exams for quick and ...

Time November 28, 2023
arrow
News | Artificial Intelligence

November 28, 2023 — iCAD, Inc., a global medical technology leader in innovative cancer-detection solutions, and ...

Time November 28, 2023
arrow
News | Digital Radiography (DR)

November 28, 2023 — Canon Medical Components USA (CMCU) - Digital Radiography (DR), global leaders in advanced flat ...

Time November 28, 2023
arrow
News | Breast Imaging

November 28, 2023 — iCAD, Inc., a global medical technology leader in innovative cancer-detection solutions, will ...

Time November 28, 2023
arrow
News | Magnetic Resonance Imaging (MRI)

November 28, 2023 — New research being presented this week at the annual meeting of the Radiological Society of North ...

Time November 28, 2023
arrow
News | Computed Tomography (CT)

November 28, 2023 — Smoking marijuana in combination with cigarettes may lead to increased damage of the lung’s air sacs ...

Time November 28, 2023
arrow
Feature | RSNA | Christine Book

November 28, 2023 — By early Monday morning, on the second day of RSNA 2023, there were significant news announcements ...

Time November 28, 2023
arrow
News | Artificial Intelligence

November 27, 2023 — Mass General Brigham and Annalise.ai today announced a collaboration to bring together their ...

Time November 27, 2023
arrow
News | RSNA

November 27, 2023 — The executive leadership teams from Canon Inc. and Cleveland Clinic gathered early on day two of the ...

Time November 27, 2023
arrow
News | Artificial Intelligence

November 27, 2023 — ConcertAI's TeraRecon, the advanced visualization and clinical AI leader, recently unveiled first-in ...

Time November 27, 2023
arrow
Subscribe Now